Question
Discuss the pathogenicity of Leishmania spp. Write symptoms and distinct features of each manifestation.
Answer :
Word Count : 484
Leishmania species are obligate intracellular protozoan parasites transmitted to humans through the bite of infected female phlebotomine sandflies. The pathogenicity of Leishmania depends on the species involved, host immune response, and parasite burden. After inoculation, promastigotes are phagocytosed by macrophages and transform into amastigotes, which multiply within the reticuloendothelial system, leading to diverse clinical manifestations collectively known as leishmaniasis. The disease mainly presents in visceral, cutaneous, mucocutaneous, and post-kala-azar dermal forms, each with distinct pathogenic mechanisms and clinical features. Visceral leishmaniasis, also known as kala-azar, is mainly caused by Leishmania donovani complex. The parasites disseminate through blood and lymphatics to visceral organs such as the spleen, liver, bone marrow, and lymph nodes. Pathogenicity is characterized by massive multiplication of amastigotes in ___ _____ _______ ______ ________ ________ ______ _________ ____.
_____ ____ ____ _________ _____ ____ _______ ________ _______ _________.
_________ _________ ___ ___ __________ _____ _______ _______ ______ ____ __________.
____ _________ ______ ____ _____ ________ _______ _____ _________ _____ ___.
______ ________ ________ _____ ___ ___ ________.
___ _______ _____ ______ ______ _________ ______ ________.
___ _________ _____ _________ ____ _________ ___ ___.
_______ ________ ________ ___ ________ ________ ____ _________ ____ __________ ________ _____.
____ _________ ___ ______ ______ ______.
____ _________ ________ ________ _______ ______ _________ ______ _____ __________.
____ ________ _______ _______ ___.
________ ___ ______ _______ _____ ______ ______.
______ _____ _____ ___ _________ _________ ______.
________ ________ ________ _____ _____ ________ _________ __________ __________.
________ ______ ________ ________ ____ _____ ____ ___ _______ _________.
________ _________ _____ ____ _______ _______ ________.
_______ ______ ___ ______ ______ ___.
_______ _______ _______ _________ _______ ____ _____ ________ ___ ______.
_____ _______ __________ _________ _____.
______ ___ ____ ________ __________ ___ _____ _____.
___ _______ _______ __________ _________.
_________ ______ __________ ________ ______ ________ ______ ___ __________ ___.
_____ ________ _________ _______ ______ ______ ________ ____ _________ _____.
______ _______ ____ _________ __________ _____ _____ ______ _________ ______.
____ __________ _______ _______ ____ ______ ______ ______ _________ ______.
___ _____ ____ __________ ____ ____ __________ ___ ___ ________.
______ _____ ____ ____ _______ __________ _____ _______ ______ _________.
____ ____ ____ ______ _______ ______ ________ _________ ____ ___.
____ ___ _________ ___ _____ ___ _________.
__________ ________ __________ _____ ________ _____ __________ _______ _________.
__________ _____ ___ ______ __________.
__________ ________ _________ ____ ___ _______ _____.
______ ________ __________ __________ ___ ______ ___ __________ _______ ___ ______ ________.
______ _________ ________ ______ _______ __________ _____.
_____ _______ _____ _______ __________ _______.
___ ______ ____ _____ _______ _______ _____ ________ ______ ___ ________ ____.
_________ __________ ___ ____ _____ ________ __________ ___ _______ ____ ________.
_____ ____ __________ _____ ______ ________ _______.
____ _________ ____ ________ ___ ___ _________ _____.
_________ _________ _____ _____ _________ _____ _______ _____ ___.
____ _______ _________ ______ _______ ______ _________ ____ _________ ______ _______ _____.
_______ ______ _________ ___ _______ _________ ______ ______ ____ __________.
Get Full Answer on WhatsApp
Leishmania species are obligate intracellular protozoan parasites transmitted to humans through the bite of infected female phlebotomine sandflies. The pathogenicity of Leishmania depends on the species involved, host immune response, and parasite burden. After inoculation, promastigotes are phagocytosed by macrophages and transform into amastigotes, which multiply within the reticuloendothelial system, leading to diverse clinical manifestations collectively known as leishmaniasis. The disease mainly presents in visceral, cutaneous, mucocutaneous, and post-kala-azar dermal forms, each with distinct pathogenic mechanisms and clinical features. Visceral leishmaniasis, also known as kala-azar, is mainly caused by Leishmania donovani complex. The parasites disseminate through blood and lymphatics to visceral organs such as the spleen, liver, bone marrow, and lymph nodes. Pathogenicity is characterized by massive multiplication of amastigotes in ___ _____ _______ ______ ________ ________ ______ _________ ____.
_____ ____ ____ _________ _____ ____ _______ ________ _______ _________.
_________ _________ ___ ___ __________ _____ _______ _______ ______ ____ __________.
____ _________ ______ ____ _____ ________ _______ _____ _________ _____ ___.
______ ________ ________ _____ ___ ___ ________.
___ _______ _____ ______ ______ _________ ______ ________.
___ _________ _____ _________ ____ _________ ___ ___.
_______ ________ ________ ___ ________ ________ ____ _________ ____ __________ ________ _____.
____ _________ ___ ______ ______ ______.
____ _________ ________ ________ _______ ______ _________ ______ _____ __________.
____ ________ _______ _______ ___.
________ ___ ______ _______ _____ ______ ______.
______ _____ _____ ___ _________ _________ ______.
________ ________ ________ _____ _____ ________ _________ __________ __________.
________ ______ ________ ________ ____ _____ ____ ___ _______ _________.
________ _________ _____ ____ _______ _______ ________.
_______ ______ ___ ______ ______ ___.
_______ _______ _______ _________ _______ ____ _____ ________ ___ ______.
_____ _______ __________ _________ _____.
______ ___ ____ ________ __________ ___ _____ _____.
___ _______ _______ __________ _________.
_________ ______ __________ ________ ______ ________ ______ ___ __________ ___.
_____ ________ _________ _______ ______ ______ ________ ____ _________ _____.
______ _______ ____ _________ __________ _____ _____ ______ _________ ______.
____ __________ _______ _______ ____ ______ ______ ______ _________ ______.
___ _____ ____ __________ ____ ____ __________ ___ ___ ________.
______ _____ ____ ____ _______ __________ _____ _______ ______ _________.
____ ____ ____ ______ _______ ______ ________ _________ ____ ___.
____ ___ _________ ___ _____ ___ _________.
__________ ________ __________ _____ ________ _____ __________ _______ _________.
__________ _____ ___ ______ __________.
__________ ________ _________ ____ ___ _______ _____.
______ ________ __________ __________ ___ ______ ___ __________ _______ ___ ______ ________.
______ _________ ________ ______ _______ __________ _____.
_____ _______ _____ _______ __________ _______.
___ ______ ____ _____ _______ _______ _____ ________ ______ ___ ________ ____.
_________ __________ ___ ____ _____ ________ __________ ___ _______ ____ ________.
_____ ____ __________ _____ ______ ________ _______.
____ _________ ____ ________ ___ ___ _________ _____.
_________ _________ _____ _____ _________ _____ _______ _____ ___.
____ _______ _________ ______ _______ ______ _________ ____ _________ ______ _______ _____.
_______ ______ _________ ___ _______ _________ ______ ______ ____ __________.
Get Full Answer on WhatsApp
IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★